MDNC Stock Overview
Medinotec Inc. engages in the research and development, production, and sale of medical devices.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Medinotec Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.00 |
| 52 Week High | US$5.00 |
| 52 Week Low | US$5.00 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDNC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.0% |
| 1Y | n/a | -1.4% | 21.9% |
Return vs Industry: Insufficient data to determine how MDNC performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how MDNC performed against the US Market.
Price Volatility
| MDNC volatility | |
|---|---|
| MDNC Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MDNC has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MDNC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 29 | Gregory Vizirgianakis | www.medinotecinc.com |
Medinotec Inc. engages in the research and development, production, and sale of medical devices. The company offers trachealators, semi-compliant coronary PTCA balloon catheters, cape cross non-compliant catheters, suction dissectors, aortic perfusion and dilation catheters, micro-CTO catheters, and tracheal stents. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations.
Medinotec Inc. Fundamentals Summary
| MDNC fundamental statistics | |
|---|---|
| Market cap | US$58.67m |
| Earnings (TTM) | -US$267.36k |
| Revenue (TTM) | US$1.22m |
48.1x
P/S Ratio-219.4x
P/E RatioIs MDNC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDNC income statement (TTM) | |
|---|---|
| Revenue | US$1.22m |
| Cost of Revenue | US$430.23k |
| Gross Profit | US$789.08k |
| Other Expenses | US$1.06m |
| Earnings | -US$267.36k |
Last Reported Earnings
May 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.023 |
| Gross Margin | 64.72% |
| Net Profit Margin | -21.93% |
| Debt/Equity Ratio | 75.9% |
How did MDNC perform over the long term?
See historical performance and comparison